-
Product Insights
Peanut Allergy Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Peanut Allergy Global Clinical Trials Review, H1, 2018" provides an overview of Peanut Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Peanut Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Pemphigus Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pemphigus Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pemphigus Vulgaris Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Wiskott-Aldrich Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Wiskott-Aldrich Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018" provides an overview of X-Linked Agammaglobulinemia clinical trials scenario. This report provides top line data relating to the clinical trials on X-Linked Agammaglobulinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Allergies Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2018" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Competitor Landscape: Psoriasis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Psoriasis (PsO) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Rheumatoid Arthritis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Lupus
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Type I Hypersensitivity Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Type I Hypersensitivity Global Clinical Trials Review, H2, 2018" provides an overview of Type I Hypersensitivity clinical trials scenario. This report provides top line data relating to the clinical trials on Type I Hypersensitivity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.